AttendMe Owl Logo
AttendMe
Evidence Evolution
Evidence Evolution
Landmark TrialRCTRandomized Controlled Trial

Intensive versus Conventional Glucose Control in Critically Ill Patients

New England Journal of Medicine2009IF: 25.4

Nice-Sugar Study Investigators

PMID: 19318384View on PubMedDOI

Abstract

In this large, international, randomized trial, we found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg per deciliter. (ClinicalTrials.gov number, NCT00220987.)

Specialty

Critical Care

Featured in Evidence Evolutions